CPhI Japan 2017 PIC/S membership accelerating international interest with market forecast to reach US$115bn by 2024

An ageing population, a growing generics market and liberalization of Over-The-Counter medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.

Read more